RAHIKA Capmatinib 200 mg Tablets 

Capmatinib is an advanced targeted therapy medicine used for the treatment of certain types of lung cancer. RAHIKA Capmatinib 200 mg Tablets contain Capmatinib, a MET inhibitor that works by blocking abnormal MET gene signals responsible for cancer cell growth and spread. It is primarily prescribed for patients with metastatic non-small cell lung cancer (NSCLC) having MET exon 14 skipping mutations.

RAHIKA Capmatinib 200 mg Tablets help slow tumor progression and improve treatment outcomes in eligible cancer patients. This medicine is usually prescribed after specialized diagnostic testing confirms the MET mutation.

Contact Details – Place Your Order Today

💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
🌐 Website: GlobMedIndia

Composition and Content

• Brand Name: RAHIKA Capmatinib 200 mg Tablets
• Generic Name: Capmatinib
• Strength: 200 mg
• Dosage Form: Oral Tablets
• Category: Anti-Cancer / Targeted Therapy Medicine
• Route of Administration: Oral Use

How RAHIKA Capmatinib 200 mg Tablets Work

Capmatinib is a targeted MET inhibitor. It blocks abnormal MET receptor signaling pathways that contribute to cancer cell growth and survival. By inhibiting these signals, the medicine helps slow or stop the spread of cancer cells in the body.

Uses of RAHIKA Capmatinib 200 mg Tablets

RAHIKA Capmatinib Tablets are primarily used for the treatment of:

• Metastatic Non-Small Cell Lung Cancer (NSCLC)
• MET Exon 14 Skipping Mutation Positive Lung Cancer
• Advanced Lung Cancer Cases Recommended by Oncologists

Doctors may prescribe it as part of personalized targeted cancer therapy.

How to Use RAHIKA Capmatinib 200 mg Tablets

• Take the tablets exactly as prescribed by your oncologist.
• Usually taken orally with or without food.
• Swallow tablets whole with water.
• Do not crush, chew, or break the tablets.
• Continue treatment as advised by your healthcare provider.
• Regular medical monitoring and blood tests may be required during therapy.

Recommended Dosage

The dosage of Capmatinib depends on the patient’s medical condition and doctor’s recommendation.

Typical dosage guidelines may include:

• 400 mg orally twice daily
• Dose adjustments depending on side effects and patient response

⚠️ Important: Do not change the dose without consulting your doctor.

Advantages of RAHIKA Capmatinib 200 mg Tablets

• Targeted therapy specifically for MET-positive NSCLC
• Helps slow cancer progression
• Personalized treatment option for eligible patients
• Oral tablet form for convenient administration
• Supports precision oncology treatment approaches
• May improve progression-free survival outcomes

Possible Side Effects

Some patients may experience:

• Nausea and vomiting
• Fatigue and weakness
• Swelling in hands or feet
• Loss of appetite
• Breathing difficulties
• Increased liver enzyme levels
• Diarrhea
• Photosensitivity reactions

Consult your healthcare provider immediately if severe side effects occur.

Storage Conditions

• Store below 25°C
• Keep away from direct sunlight and moisture
• Store in original packaging
• Keep out of reach of children
• Do not use expired medicine

Alternative Indian Brands for Capmatinib Tablets

Popular alternatives and related targeted therapy medicines may include:

• Tabrecta Tablets
• Capmax Tablets
• Capmatinib Generic Tablets
• MET Inhibitor Targeted Therapy Tablets

Availability may vary depending on import regulations and stock availability.

Why Choose GlobMedIndia?

• Trusted Global Medicine Exporter
• Genuine Oncology Medicines
• International Shipping Available
• Secure Packaging & Safe Delivery
• Affordable Export Pricing
• Professional Customer Support
• Fast Worldwide Delivery Services

We export anti-cancer medicines across the United States including:

• California
• Washington
• Chicago
• Los Angeles
• Houston
• Phoenix
• Austin
• Columbus
• Philadelphia
• San Antonio
• San Diego
• Dallas
• Jacksonville

Buy Now RAHIKA Capmatinib 200 mg Tablets from GlobMedIndiaa – Trusted Exporter of Anti-Cancer Medicines Worldwide